FBIO (FBIO) Stock Price & Analysis
FBIO (FBIO) rose 0.37% to USD 2.72 as of September 8, 2026 at 09:36 UTC, according to Nexqual real-time market data.
FBIO last closed at USD 2.72; the session ranged USD 2.68–2.74 on volume of 168,144 shares. Market capitalization is —, with a 52-week range of USD 2.18–4.53 (NCM). Source: Nexqual, September 8, 2026 at 09:36 UTC.
Key Statistics (as of September 8, 2026 at 09:36 UTC)
| Price | USD 2.72 |
|---|---|
| Change | ▲ 0.37% (up) |
| Previous Close | USD 2.72 |
| Open | USD 2.72 |
| Day Range | USD 2.68 – 2.74 |
| 52-Week Range | USD 2.18 – 4.53 |
| Volume | 168,144 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (FBIO)
Nexqual's technical model rates FBIO "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:36 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.73 (neutral) |
| vs SMA50 | Below (USD 3.02) |
| MACD | -0.08 (negative) |
From FBIO's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBIO | Mustang Bio, Inc. | USD 0.54 | ▼ 0.02% |
| ATXI | Avenue Therapeutics, Inc. | USD 0.54 | ▼ 4.56% |
| VSTM | Verastem, Inc. | USD 8.2 | ▲ 2.24% |
| LPCN | Lipocine Inc. | USD 2.45 | ▲ 4.03% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:36 UTC. This page is informational and not investment advice.